Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 282

Similar articles for PubMed (Select 16421367)

1.

Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.

Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH.

N Engl J Med. 2006 Jan 19;354(3):261-9.

3.

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL; Prevention and Observation of Surgical End Points Study Group.

N Engl J Med. 2002 May 23;346(21):1616-22. Epub 2002 May 20.

4.

Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.

Chen LM, Yang KY, Little SE, Cheung MK, Caughey AB.

Obstet Gynecol. 2007 Jul;110(1):18-25.

PMID:
17601891
5.

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K.

N Engl J Med. 2002 May 23;346(21):1609-15. Epub 2002 May 20.

6.

Prophylactic oophorectomy in women at increased cancer risk.

Domchek SM, Rebbeck TR.

Curr Opin Obstet Gynecol. 2007 Feb;19(1):27-30. Review.

PMID:
17218848
7.

Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.

Kwon JS, Sun CC, Peterson SK, White KG, Daniels MS, Boyd-Rogers SG, Lu KH.

Cancer. 2008 Jul 15;113(2):326-35. doi: 10.1002/cncr.23554.

8.

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

Finch A, Beiner M, Lubinski J, Lynch HT, Moller P, Rosen B, Murphy J, Ghadirian P, Friedman E, Foulkes WD, Kim-Sing C, Wagner T, Tung N, Couch F, Stoppa-Lyonnet D, Ainsworth P, Daly M, Pasini B, Gershoni-Baruch R, Eng C, Olopade OI, McLennan J, Karlan B, Weitzel J, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group.

JAMA. 2006 Jul 12;296(2):185-92.

PMID:
16835424
9.

Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.

Pistorius S, Kruger S, Hohl R, Plaschke J, Distler W, Saeger HD, Schackert HK.

Gynecol Oncol. 2006 Aug;102(2):189-94. Epub 2006 Feb 14.

PMID:
16476474
10.

Prophylactic surgery in Lynch syndrome.

Celentano V, Luglio G, Antonelli G, Tarquini R, Bucci L.

Tech Coloproctol. 2011 Jun;15(2):129-34. doi: 10.1007/s10151-010-0666-0. Epub 2011 Feb 2. Review.

PMID:
21287222
11.

Reducing the risk of gynecologic cancer in the Lynch syndrome.

Offit K, Kauff ND.

N Engl J Med. 2006 Jan 19;354(3):293-5. No abstract available.

PMID:
16421372
12.
13.

Primary peritoneal cancer in Lynch syndrome: a clinical-pathologic report of a case and analysis of the literature.

Ghezzi F, Uccella S, Cromi A, Bogani G, Donadello N, Riva C.

Int J Gynecol Pathol. 2013 Mar;32(2):163-6. doi: 10.1097/PGP.0b013e31825ac5c9. Review.

PMID:
23370650
14.

Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.

Rutter JL, Wacholder S, Chetrit A, Lubin F, Menczer J, Ebbers S, Tucker MA, Struewing JP, Hartge P.

J Natl Cancer Inst. 2003 Jul 16;95(14):1072-8.

15.

Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.

Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S, Bandipalliam P, Chen LM, Allen B, Conrad P, Terdiman J, Sun C, Daniels M, Burke T, Gershenson DM, Lynch H, Lynch P, Broaddus RR.

Obstet Gynecol. 2005 Mar;105(3):569-74.

PMID:
15738026
16.

Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families.

Boilesen AE, Bisgaard ML, Bernstein I.

Acta Obstet Gynecol Scand. 2008;87(11):1129-35. doi: 10.1080/00016340802443806.

PMID:
18972272
17.

Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.

Villella JA, Parmar M, Donohue K, Fahey C, Piver MS, Rodabaugh K.

Gynecol Oncol. 2006 Sep;102(3):475-9. Epub 2006 Feb 13.

PMID:
16473397
18.

Unexpected endometrial cancer at prophylactic hysterectomy in a woman with hereditary nonpolyposis colon cancer.

Chung L, Broaddus R, Crozier M, Luthraa R, Levenback C, Lu K.

Obstet Gynecol. 2003 Nov;102(5 Pt 2):1152-5.

PMID:
14607039
19.

Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.

Meeuwissen PA, Seynaeve C, Brekelmans CT, Meijers-Heijboer HJ, Klijn JG, Burger CW.

Gynecol Oncol. 2005 May;97(2):476-82.

PMID:
15863147
20.

Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer.

Berek JS, Chalas E, Edelson M, Moore DH, Burke WM, Cliby WA, Berchuck A; Society of Gynecologic Oncologists Clinical Practice Committee.

Obstet Gynecol. 2010 Sep;116(3):733-43. doi: 10.1097/AOG.0b013e3181ec5fc1. Review.

PMID:
20733460
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk